12 Results for "

TWIST1

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "TWIST1" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-N2013
CAS No.: 13395-02-3
Synonyms: Aristololactam; Aristolactam
Aristolactam I is an AQP1 inhibitor and Aristolochic acid I metabolite. Aristolactam I can be isolated from Aristolochia plants. Aristolactam I downregulates Twist1 expression, increases E-cadherin expression, and activates the TGF-β/Smad signaling pathway. Aristolactam I has anticancer activity against breast cancer. Aristolactam I is nephrotoxic. Aristolactam I is mainly used in the study of breast cancer and kidney diseases such as renal interstitial fibrosis [1] .
loading...
    loading...
Cat. No.: HY-RS15281
Research Areas:  

Others

TWIST1 Human Pre-designed siRNA Set A contains three designed siRNAs for TWIST1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS20201
Research Areas:  

Others

Twist1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Twist1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS26705
Research Areas:  

Others

Twist1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Twist1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-179452
Research Areas:  

Cancer

KRAS G13D-IN-2 (compound 8B) is a potent orally active KRAS G13D inhibitor with IC50 values of 1.95 μM (HCT-116 G13D) and 2.16 μM (HCT-15 G13D). KRAS G13D-IN-2 induces G1-phase arrest and mitochondrial membrane depolarization. KRAS G13D-IN-2 induces senescence through CDK6/TWIST1 inhibition. KRAS G13D-IN-2 inhibits tumor growth in murine models. KRAS G13D-IN-2 can be used for KRAS G13D-mutant colorectal cancer research [1].
loading...
    loading...
Cat. No.: HY-N2013R
CAS No.: 13395-02-3
Synonyms: Aristololactam (Standard); Aristolactam (Standard)
Aristolactam I (Standard) is the analytical standard of Aristolactam I. This product is intended for research and analytical applications. Aristolactam I is an AQP1 inhibitor and Aristolochic acid I metabolite. Aristolactam I can be isolated from Aristolochia plants. Aristolactam I downregulates Twist1 expression, increases E-cadherin expression, and activates the TGF-β/Smad signaling pathway. Aristolactam I has anticancer activity against breast cancer. Aristolactam I is nephrotoxic. Aristolactam I is mainly used in the study of breast cancer and kidney diseases such as renal interstitial fibrosis [1] .
loading...
    loading...
Cat. No.: HY-P86342

Host:  

Rabbit

Application:  

WB, ICC/IF, IP, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-179340
CAS No.: 2699749-60-3
Target:  

Apoptosis

Research Areas:  

Cancer

Antiproliferative agent-74 (Compound 19a) is an anti-proliferative agent. Antiproliferative agent-74 suppresses Twist1 expression, induces weak Apoptosis. Antiproliferative agent-74 displays anti-proliferative activity against non-small cell lung cancer cells [1].
loading...
    loading...
Cat. No.: HY-P84596
Synonyms: SCS; ACS3; CRS1; BPES2; BPES3; TWIST; bHLHa38

Host:  

Mouse

Application:  

WB, IHC-P, ICC/IF, FC, ELISA

Reactivity:  

Human, Mouse, Rat, Rabbit

loading...
    loading...
Cat. No.: HY-P84596A
Synonyms: SCS; ACS3; CRS1; BPES2; BPES3; TWIST; bHLHa38

Host:  

Mouse

Application:  

WB, IHC-P, ICC/IF, FC, ELISA

Reactivity:  

Human, Mouse, Rat, Rabbit

loading...
    loading...
Cat. No.: HY-P81173
Synonyms: ACS3; B-HLH DNA binding protein; bHLHa38; BPES2; BPES3; Class A basic helix-loop-helix protein 38; CRS1; H-TWIST; OTTHUMP00000116043; SCS; TWIST basic helix loop helix transcription factor 1; TWIST homolog 1 (Drosophila); TWIST homolog 1; TWIST homolog of drosophila; TWIST related protein 1; TWIST-related protein 1; TWIST1; TWST1_HUMAN.

Host:  

Mouse

Application:  

WB, IHC-P, ICC/IF, FC

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-182069
Research Areas:  

Cancer

CDK9-IN-47 is an orally active and selective CDK9 inhibitor with an IC50 of 1.4 nM. CDK9-IN-47 inhibits tumor cell proliferation, migration and invasion, and induces apoptosis. CDK9-IN-47 can be used for the research of triple-negative breast cancer [1].
loading...
    loading...
  • 1